(Q53369321)
Statements
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. (English)
R Pettengell
J A Radford
G R Morgenstern
J H Scarffe
M Harris
P J Woll
D P Deakin
D Ryder
P M Wilkinson
D Crowther
1 February 1996
14
2
586-592